RNAimmune is a company specializing in the field of messenger RNA (mRNA) technology. The principle of its proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a range of diseases. The company applies its technologies for the development of cancer therapies, antibody therapies, the treatment of rare diseases, and prophylactic vaccines.
|HQ||Gaithersburg, MD, US||Map|
RNAimmune total Funding
RNAimmune latest funding size
Time since last funding
|6 months ago|
|Terra Magnum Capital Partners ("TMCP"), Smooth River, Hong Kong Hongrun, Shanghai Walga Biotechnology, High Forest Investment, Terra Magnum Sigma|
Who are RNAimmune key executives?
RNAimmune's key executives are Dong Shen, Kevin He and Nigel Yip.
Who are RNAimmune competitors?
Competitors of RNAimmune include Ufovax, Stemirna and CureVac.
Where is RNAimmune headquarters?
RNAimmune headquarters is located at 401 Professional Dr #280, Gaithersburg.
Where are RNAimmune offices?
RNAimmune has an office in Gaithersburg.
How many offices does RNAimmune have?
RNAimmune has 1 office.
Receive alerts for 300+ data fields across thousands of companies